Skip to main content
CRESCENT BIOPHARMA, INC. logo

CRESCENT BIOPHARMA, INC. — Investor Relations & Filings

Ticker · CBIO ISIN · US38000Q1022 US Manufacturing
Open in API
Filings indexed 611 across all filing types
Latest filing 2023-11-03 Earnings Release
Country US United States of America
Listing US CBIO

About CRESCENT BIOPHARMA, INC.

https://www.crescentbiopharma.com/

Crescent Biopharma, Inc. is a biopharmaceutical company dedicated to researching and developing the next wave of cancer therapies. The company's vision is to build a world-leading oncology organization by focusing on revolutionary shifts in the field to transform cancer treatment. Its strategy involves advancing a pipeline of therapies with multiple modalities, including precision-engineered small molecule therapeutics, designed to address cancer on various fronts. Crescent Biopharma aims to deliver a new standard of care for people living with cancer through its innovative pipeline.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 3, 2023, reporting the financial results for the third quarter ended September 30, 2023. It includes a press release as Exhibit 99.1 announcing the financial results. The text explicitly states that the press release is furnished and incorporated by reference, and the document itself is a current report rather than the full financial statements or detailed analysis. The length is 4067 characters, which is relatively short and consistent with a current report filing. The document does not contain comprehensive financial statements or detailed management discussion, but rather an announcement of financial results. Therefore, this is best classified as an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only.
2023-11-03 English
10-Q
Interim / Quarterly Report 9M 2023
2023-11-03 English
FORM 4 SUBMISSION
Director's Dealing
2023-10-03 English
FORM 4 SUBMISSION
Director's Dealing
2023-10-03 English
FORM 4 SUBMISSION
Director's Dealing
2023-10-03 English
FORM 4 SUBMISSION
Director's Dealing
2023-09-25 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.